ES2589169A1 - Uso de la pentoxifilina y de una composición farmacéutica para elaborar un medicamento para prevenir el envejecimiento prematuro en humanos - Google Patents

Uso de la pentoxifilina y de una composición farmacéutica para elaborar un medicamento para prevenir el envejecimiento prematuro en humanos Download PDF

Info

Publication number
ES2589169A1
ES2589169A1 ES201530616A ES201530616A ES2589169A1 ES 2589169 A1 ES2589169 A1 ES 2589169A1 ES 201530616 A ES201530616 A ES 201530616A ES 201530616 A ES201530616 A ES 201530616A ES 2589169 A1 ES2589169 A1 ES 2589169A1
Authority
ES
Spain
Prior art keywords
humans
prepare
pharmaceutical composition
premature aging
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201530616A
Other languages
English (en)
Other versions
ES2589169B1 (es
Inventor
Juan Francisco NAVARRO GONZÁLEZ
Alberto ORTIZ ARDÚAN
María Dolores SÁNCHEZ NIÑO
Ana Belén BARTOLOMÉ SANZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacion Canaria De Investigacion Sanitaria (funcanis)
Fund Canaria De Investig Sanitaria (funcanis)
Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz
Original Assignee
Fundacion Canaria De Investigacion Sanitaria (funcanis)
Fund Canaria De Investig Sanitaria (funcanis)
Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion Canaria De Investigacion Sanitaria (funcanis), Fund Canaria De Investig Sanitaria (funcanis), Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz filed Critical Fundacion Canaria De Investigacion Sanitaria (funcanis)
Priority to ES201530616A priority Critical patent/ES2589169B1/es
Publication of ES2589169A1 publication Critical patent/ES2589169A1/es
Application granted granted Critical
Publication of ES2589169B1 publication Critical patent/ES2589169B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de la pentoxifilina y de una composición farmacéutica para elaborar un medicamento para prevenir el envejecimiento prematuro en humanos. Uso de la pentoxifilina y de una composición farmacéutica que comprende pentoxifilina para elaborar un medicamento para prevenir el envejecimiento prematuro en humanos. Dicho envejecimiento prematuro está causado por un déficit de expresión de la hormona antienvejecimiento Klotho.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES201530616A 2015-05-06 2015-05-06 Uso de la pentoxifilina y de una composición farmacéutica para elaborar un medicamento para prevenir el envejecimiento prematuro en humanos Active ES2589169B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201530616A ES2589169B1 (es) 2015-05-06 2015-05-06 Uso de la pentoxifilina y de una composición farmacéutica para elaborar un medicamento para prevenir el envejecimiento prematuro en humanos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201530616A ES2589169B1 (es) 2015-05-06 2015-05-06 Uso de la pentoxifilina y de una composición farmacéutica para elaborar un medicamento para prevenir el envejecimiento prematuro en humanos

Publications (2)

Publication Number Publication Date
ES2589169A1 true ES2589169A1 (es) 2016-11-10
ES2589169B1 ES2589169B1 (es) 2017-08-29

Family

ID=57226504

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201530616A Active ES2589169B1 (es) 2015-05-06 2015-05-06 Uso de la pentoxifilina y de una composición farmacéutica para elaborar un medicamento para prevenir el envejecimiento prematuro en humanos

Country Status (1)

Country Link
ES (1) ES2589169B1 (es)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000066102A2 (en) * 1999-04-29 2000-11-09 City Of Hope Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000066102A2 (en) * 1999-04-29 2000-11-09 City Of Hope Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MIQUEL J Causes and prevention of premature aging.Geriatrika (Madrid) 1994 00/00/1994 VOL: 10 No: 7 Pags: 19-24 ISSN 0212-9744. Página 22, párrafo segundo. *
PARNETTI, L. y col. THE ROLE OF HEMORHEOLOGICAL FACTORS IN THE AGING BRAIN LONG-TERM THERAPY WITH PENTOXIFYLLINE TRENTAL 400 IN ELDERLY PATIENTS WITH INITIAL MENTAL DETERIORATION. Pharmatherapeutica, 1986, vol. 4, N? 10, p?ginas 617-627. Resumen *

Also Published As

Publication number Publication date
ES2589169B1 (es) 2017-08-29

Similar Documents

Publication Publication Date Title
BR112018076601A2 (pt) formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação
DOP2018000297A (es) Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
CL2016000952A1 (es) Derivados de carboxamida y su uso como medicamentos para el tratamiento de la hepatitis b
CL2015003395A1 (es) Derivados pirazolopirrolidina y su uso en el tratamiento de la enfermedad
CL2015002733A1 (es) Composición farmacéutica de clorhidrato de s-cetamina.
CL2015002767A1 (es) Compuestos terapéuticos y composiciones
BR112018010671A2 (pt) dispositivos e métodos de distribuição de fármaco com mudança de forma
BR112018070199A2 (pt) composição farmacêutica de hormônio esteroide
CO2018004857A2 (es) Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer
BR112019011702A2 (pt) tratamento de uma doença do trato gastrointestinal com um inibidor de il-12/il-23 liberado usando um dispositivo ingerível
BR112016015838A8 (pt) compostos heterocíclicos aromáticos, composição farmacêutica compreendendo os referidos compostos e produto de combinação
CL2015000942A1 (es) Compuestos de benceno sustituido.
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
BR112016019592A8 (pt) Composto, uso de um composto, e, composição farmacêutica
CO2017002472A2 (es) Formulación de acetato de abiraterona
BR112017012406A2 (pt) formulação com relação fixa de insulina glargina/lixisenatida
UY35455A (es) Inhibidores tripeptidicos de la epoxicetona proteasa
AR094707A1 (es) Compuesto de quinazolin-4-amina, composición farmacéutica que lo comprende y su uso para el tratamiento de una enfermedad mediada por la quinasa rip2
ECSP16086247A (es) (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
BR112014032764A2 (pt) composição farmacêutica contendo fimasartana e hidroclorotiazida
ES2540151A1 (es) Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
ECSP16086232A (es) (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
BR112018008076A2 (pt) derivados de lapachona contendo dois centros redox e métodos de uso dos mesmos
BR112017024126B8 (pt) Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2589169

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20170829